NCT05761327Completed
Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis
Source: ClinicalTrials.gov · Last updated 25 Mar 2024
Brief summary (registry, in English)
The aim of the study was to examine and compare the effects of Mediterranean diet, curcumin supplementation with Mediterranean diet in individuals with ulcerative colitis, and resveratrol supplementation with Mediterranean diet in individuals with ulcerative colitis, on disease symptoms, quality of life, and inflammatory biomarkers.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 11 Feb 2023
- Start date
- 3 Jun 2022
- Primary completion date
- 18 Feb 2023
- Lead sponsor
- Ardahan University
- Diseases
- Ulcerative colitis
- NCT number
- NCT05761327
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 3 Jun 2022 to the primary completion date, 18 Feb 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking one of the anti-inflammatory and antibiotic drugs,
Other illness
- History of chronic disease (such as diabetes), hypothyroidism and hyperthyroidism, liver, kidney and cardiovascular diseases, polycystic ovary syndrome and Cushing's syndrome,
Other
- Women during pregnancy or lactation
- Not meeting the inclusion criteria,
Who the study is looking for
- Male and female patients aged \>18 years,
- Those previously diagnosed with ulcerative colitis and/or newly diagnosed with clinical course, consistent histology and endoscopy by a gastroenterologist,
- Mild and Moderate activity disease was confirmed by the Truelove-Witts Severity Index,
- Using a fixed dose of 5 - aminosalicylic acid (mesalazine) and/or azathioprine,
- Who did not receive nutrition therapy in the last 3 months,
- Not using anti-inflammatory drugs and antibiotic drugs in the last 4 weeks,
- Not using curcumin and resveratrol supplements before participating in the study,
- Agreeing to participate in the study voluntarily,
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Malatya Training and Research Hospital Coordinator of this site? Confirm its status | Malatya | Turkey (Türkiye) | Unknown status |
| Inonu University Turgut Ozal Medical Center Coordinator of this site? Confirm its status | Malatya | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.